[EN] HEMOGLOBIN MODIFIER COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS MODIFICATEURS D'HÉMOGLOBINE ET LEURS UTILISATIONS
申请人:FRONTHERA U S PHARMACEUTICALS LLC
公开号:WO2017218960A1
公开(公告)日:2017-12-21
Described herein are compounds, including pharmaceutically acceptable salts thereof, methods of making such compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat, prevent or diagnose blood-based diseases, disorders or conditions.
本文描述了化合物,包括其药用可接受的盐,制备这些化合物的方法,包含这些化合物的药物组合物,以及使用这些化合物治疗、预防或诊断基于血液的疾病、紊乱或状况的方法。